Patents by Inventor Thomas M. Ramseier

Thomas M. Ramseier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10689640
    Abstract: The present invention provides an array for rapidly identifying a host cell population capable of producing a heterologous recombinant protein with improved yield and/or quality. The array comprises one or more host cell populations that have been genetically modified to increase the expression of one or more target genes involved in protein production, decrease the expression of one or more target genes involved in protein degradation, or both. One or more of the strains in the array may express the heterologous recombinant protein of interest in a periplasm compartment or may secrete the heterologous recombinant protein extracellularly through an outer cell wall. The strain arrays are useful for screening for improved expression of any protein of interest including therapeutic proteins, hormones, growth factors, extracellular receptors or ligands, proteases, kinases, blood proteins, chemokines, cytokines, antibodies and the like.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: June 23, 2020
    Assignee: Pfenex Inc.
    Inventors: Diane M. Retallack, Charles H. Squires, Thomas M. Ramseier, Russell J. Coleman, Jane C. Schneider, Charles D. Hershberger
  • Publication number: 20170183646
    Abstract: The present invention provides an array for rapidly identifying a host cell population capable of producing heterologous protein with improved yield and/or quality. The array comprises one or more host cell populations that have been genetically modified to increase the expression of one or more target genes involved in protein production, decrease the expression of one or more target genes involved in protein degradation, or both. One or more of the strains in the array may express the heterologous protein of interest in a periplasm compartment, or may secrete the heterologous protein extracellularly through an outer cell wall. The strain arrays are useful for screening for improved expression of any protein of interest, including therapeutic proteins, hormones, a growth factors, extracellular receptors or ligands, proteases, kinases, blood proteins, chemokines, cytokines, antibodies and the like.
    Type: Application
    Filed: December 19, 2016
    Publication date: June 29, 2017
    Inventors: Diane M. Retallack, Charles H. Squires, Thomas M. Ramseier, Russell J. Coleman, Jane C. Schneider, Charles D. Hershberger
  • Patent number: 9580719
    Abstract: The present invention provides an array for rapidly identifying a host cell population capable of producing a heterologous protein with improved yield and/or quality. The array comprises one or more host cell populations that have been genetically modified to increase the expression of one or more target genes involved in protein production, decrease the expression of one or more target genes involved in protein degradation, or both. One or more of the strains in the array may express the heterologous protein of interest in a periplasm compartment or may secrete the heterologous protein extracellularly through an outer cell wall. The strain arrays are useful for screening for improved expression of any protein of interest including therapeutic proteins, hormones, growth factors, extracellular receptors or ligands, proteases, kinases, blood proteins, chemokines, cytokines, antibodies and the like.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: February 28, 2017
    Assignee: PFENEX, INC.
    Inventors: Diane M. Retallack, Charles H. Squires, Thomas M. Ramseier, Russell J. Coleman, Jane C. Schneider, Charles D. Hershberger
  • Publication number: 20170016035
    Abstract: Methods and genetically engineered hosts for the production of 3-carbon, 4-carbon and 5-carbon products, polymers and copolymers in methylotrophic bacteria are described herein.
    Type: Application
    Filed: June 27, 2014
    Publication date: January 19, 2017
    Inventors: Thomas M. Ramseier, Dong-eun Chang, Jian-rong Gao, William R. Farmer, Oliver P. Peoples
  • Patent number: 9394571
    Abstract: The present invention provides an array for rapidly identifying a host cell population capable of producing a heterologous protein with improved yield and/or quality. The array comprises one or more host cell populations that have been genetically modified to increase the expression of one or more target genes involved in protein production, decrease the expression of one or more target genes involved in protein degradation, or both. One or more of the strains in the array may express the heterologous protein of interest in a periplasm compartment or may secrete the heterologous protein extracellularly through an outer cell wall. The strain arrays are useful for screening for improved expression of any protein of interest including therapeutic proteins, hormones, growth factors, extracellular receptors or ligands, proteases, kinases, blood proteins, chemokines, cytokines, antibodies and the like.
    Type: Grant
    Filed: April 25, 2008
    Date of Patent: July 19, 2016
    Assignee: PFENEX INC.
    Inventors: Thomas M. Ramseier, Russell J. Coleman, Jane C. Schneider, Charles D. Hershberger, Diane M. Retallack, Charles H. Squires
  • Patent number: 9109229
    Abstract: This invention is a process for improving the production levels of recombinant proteins or peptides or improving the level of active recombinant proteins or peptides expressed in host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recombinant protein expression. The process can improve protein production or can improve protein quality, for example, by increasing solubility of a recombinant protein.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: August 18, 2015
    Assignee: Pfenex Inc.
    Inventors: Thomas M. Ramseier, Hongfan Jin, Charles H. Squires
  • Patent number: 9084467
    Abstract: Processes and methods for making biobased gamma-butyrolactone from renewable carbon resources are described herein.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: July 21, 2015
    Assignee: Metabolix, Inc.
    Inventors: Johan van Walsem, Erik Anderson, John Licata, Kevin A. Sparks, William R. Farmer, Christopher Mirley, Jeffrey A. Bickmeier, Ann D'Ambruoso, Frank A. Skraly, Thomas M. Ramseier, Melarkode S. Sivasubramanian, Yossef Shabtai
  • Publication number: 20150159184
    Abstract: Methods and genetically engineered hosts for the production of poly-4-hydroxybutrate and 4-carbon products are described herein.
    Type: Application
    Filed: March 4, 2013
    Publication date: June 11, 2015
    Inventors: Thomas M. Ramseier, Christopher W.J. McChalicher, William R. Farmer, Zhigang Zhang, Dong-Eun Chang, Jeff Bickmeier, Julie Beaulieu, Catherine Morse
  • Publication number: 20140170714
    Abstract: Post purification processes and methods for making pure biobased gamma-butyrolactone from renewable carbon resources comprising filtration and/or distillation and/or peroxide treatment are described herein.
    Type: Application
    Filed: August 10, 2012
    Publication date: June 19, 2014
    Applicant: METABOLIX, INC.
    Inventors: Johan Van Walsem, John Licata, Erik A. Anderson, Kevin A. Sparks, William R. Farmer, Christopher Mirley, Jeffrey A. Bickmeier, Frank A. Skraly, Thomas M. Ramseier, Ann D'Ambruoso, Melarkode S. Sivasubramanian, Yossef Shabtai, Derek Samuelson, Stephen Harris
  • Publication number: 20140162279
    Abstract: This invention is a process for improving the production levels of recombinant proteins or peptides or improving the level of active recombinant proteins or peptides expressed in host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recombinant protein expression. The process can improve protein production or can improve protein quality, for example, by increasing solubility of a recombinant protein.
    Type: Application
    Filed: November 4, 2013
    Publication date: June 12, 2014
    Applicant: PFENEX INC.
    Inventors: THOMAS M. RAMSEIER, HONGFAN JIN, CHARLES H. SQUIRES
  • Publication number: 20140114082
    Abstract: Processes and methods for making biobased tetrahydrofuran products from renewable carbon resources are described herein.
    Type: Application
    Filed: June 8, 2012
    Publication date: April 24, 2014
    Applicant: METABOLIX, INC.
    Inventors: Johan van Walsem, Erik Anderson, John Licata, Kevin A. Sparks, William R. Farmer, Christopher Mirley, Jeffrey A. Bickmeier, Ann D'Ambruoso, Frank Skraly, Thomas M. Ramseier, M. S. Sivasubramanian, Oliver P. Peoples, Yossef Shabtai
  • Patent number: 8603824
    Abstract: This invention is a process for improving the production levels of recombinant proteins or peptides or improving the level of active recombinant proteins or peptides expressed in host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recombinant protein expression. The process can improve protein production or can improve protein quality, for example, by increasing solubility of a recombinant protein.
    Type: Grant
    Filed: July 26, 2005
    Date of Patent: December 10, 2013
    Assignee: Pfenex, Inc.
    Inventors: Thomas M. Ramseier, Hongfan Jin, Charles H. Squires
  • Publication number: 20130288317
    Abstract: Disclosed are methods including organisms genetically engineered to make useful products when grown on glucose as a carbon source. The organisms are genetically engineered to produce various useful products such as polyhydroxyalkanoates (PHA) monomers, polymers, and copolymers, diols, alcohols, and other useful chemicals.
    Type: Application
    Filed: March 14, 2013
    Publication date: October 31, 2013
    Inventors: Thomas M. Ramseier, Christopher W.J. McChalicher
  • Publication number: 20130046075
    Abstract: A double-walled plastic jar for cosmetic materials, having an inner compartment to hold the cosmetic, and an annular outer side wall defining the exterior of the jar. The inner compartment carries the lip that seals with a screw cap, and also carries an external skirt, which latter has the screw threads for engagement by the cap. In addition, a weight is disposed in a-concealed manner in the base of the jar, between the walls, to give the jar a heft feel, characteristic of glass or thick plastic walls.
    Type: Application
    Filed: April 4, 2011
    Publication date: February 21, 2013
    Inventors: Johan van Walsem, Erik Anderson, John Licata, Kevin A. Sparks, William R. Farmer, Christopher Mirley, Jeffrey A. Bickmeier, Ann D'Ambruoso, Frank A. Skraly, Thomas M. Ramseier, M.S. Sivasubramanian, Yossef Shabtai
  • Publication number: 20100137162
    Abstract: The present invention provides an array for rapidly identifying a host cell population capable of producing heterologous protein with improved yield and/or quality. The array comprises one or more host cell populations that have been genetically modified to increase the expression of one or more target genes involved in protein production, decrease the expression of one or more target genes involved in protein degradation, or both. One or more of the strains in the array may express the heterologous protein of interest in a periplasm compartment, or may secrete the heterologous protein extracellularly through an outer cell wall. The strain arrays are useful for screening for improved expression of any protein of interest, including therapeutic proteins, hormones, a growth factors, extracellular receptors or ligands, proteases, kinases, blood proteins, chemokines, cytokines, antibodies and the like.
    Type: Application
    Filed: October 30, 2009
    Publication date: June 3, 2010
    Applicant: Pfenex Biopharmaceuticals, Inc.
    Inventors: Diane M. Retallack, Charles H. Squires, Thomas M. Ramseier, Russell J. Coleman, Jane C. Schneider, Charies D. Hershberger
  • Patent number: 7618799
    Abstract: Compositions and methods for improving expression and/or secretion of protein or polypeptide of interest in a host cell are provided. Compositions comprising a coding sequence for a bacterial secretion signal peptide are provided. The coding sequences can be used in vector constructs or expression systems for transformation and expression of a protein or polypeptide of interest in a host cell. The compositions of the invention are useful for increasing accumulation of properly processed proteins in the periplasmic space of a host cell, or for increasing secretion of properly processed proteins from the host cell. In particular, isolated secretion signal peptide-encoding nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the nucleic acid molecules are encompassed.
    Type: Grant
    Filed: January 30, 2008
    Date of Patent: November 17, 2009
    Assignee: Dow Global Technologies Inc
    Inventors: Russell J. Coleman, Diane Retallack, Jane C. Schneider, Thomas M. Ramseier, Charles D. Hershberger, Stacey Lee, Sol M. Resnick
  • Publication number: 20090062143
    Abstract: The present invention provides methods and compositions for producing heterologous protein with improved yield and/or quality. A library of randomized ribosomal binding site sequences is provided for the identification of a translation initiation region sequence optimal for expression of the heterologous protein. Also provided are novel ribosomal binding site sequences, and vectors and host cells having those sequences. The library of randomized sequences is useful for screening for improved expression of any protein of interest, including therapeutic proteins, hormones, a growth factors, extracellular receptors or ligands, proteases, kinases, blood proteins, chemokines, cytokines, antibodies and the like.
    Type: Application
    Filed: August 4, 2008
    Publication date: March 5, 2009
    Applicant: Dow Global Technologies Inc.
    Inventors: Thomas M. Ramseier, Russell J. Coleman, Jane C. Schneider
  • Publication number: 20080269070
    Abstract: The present invention provides an array for rapidly identifying a host cell population capable of producing heterologous protein with improved yield and/or quality. The array comprises one or more host cell populations that have been genetically modified to increase the expression of one or more target genes involved in protein production, decrease the expression of one or more target genes involved in protein degradation, or both. One or more of the strains in the array may express the heterologous protein of interest in a periplasm compartment, or may secrete the heterologous protein extracellularly through an outer cell wall. The strain arrays are useful for screening for improved expression of any protein of interest, including therapeutic proteins, hormones, a growth factors, extracellular receptors or ligands, proteases, kinases, blood proteins, chemokines, cytokines, antibodies and the like.
    Type: Application
    Filed: April 25, 2008
    Publication date: October 30, 2008
    Applicant: Dow Global Technologies, Inc.
    Inventors: Thomas M. Ramseier, Russell J. Coleman, Jane C. Schneider, Charles D. Hershberger
  • Publication number: 20080193974
    Abstract: Compositions and methods for improving expression and/or secretion of protein or polypeptide of interest in a host cell are provided. Compositions comprising a coding sequence for a bacterial secretion signal peptide are provided. The coding sequences can be used in vector constructs or expression systems for transformation and expression of a protein or polypeptide of interest in a host cell. The compositions of the invention are useful for increasing accumulation of properly processed proteins in the periplasmic space of a host cell, or for increasing secretion of properly processed proteins from the host cell. In particular, isolated secretion signal peptide-encoding nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the nucleic acid molecules are encompassed.
    Type: Application
    Filed: January 30, 2008
    Publication date: August 14, 2008
    Applicant: DOW GLOBAL TECHNOLOGIES, INC.
    Inventors: Russell J. Coleman, Diane Retallack, Jane C. Schneider, Thomas M. Ramseier, Charles D. Hershberger, Stacey Lee, Sol M. Resnick
  • Publication number: 20030036176
    Abstract: DNA and protein sequences from Xanthomonas campestris pv. campestris, which may be targeted for activity reduction or enhancement using directed genetic engineering. Transformed microorganisms having reduced activity of at least one protein, e.g. galactomannanase, can be provided by disrupting a gene encoding the protein or introducing antisense nucleic acid sequence, providing xanthan gum essentially free of galactomannanase, amylase, cellulase or protease activity.
    Type: Application
    Filed: August 10, 2001
    Publication date: February 20, 2003
    Inventors: Stanley G. Bower, Thomas M. Ramseier